READING, England, March 11, 2014 /PRNewswire/ -- OpenText™ (NASDAQ: OTEX, TSX: OTC), the global leader in Enterprise Information Management (EIM), announced today that it has been selected by the Royal Free London NHS Foundation Trust to manage its scanned legacy case-notes.
OpenText's Content Suite, the core and foundation Suite for OpenText EIM, is designed to help healthcare providers maximise the value of the information they hold and minimise risk associated with information management.
Set against the backdrop of the Department of Health's NHS Digital Health Strategy to make the NHS paperless by 2018, OpenText's Content Suite will be utilised to store, manage and make available digitised copies of the Royal Free's paper care records. The system will be integrated with the trust's Cerner Electronic Patient Records (EPR) system, and will ensure that clinicians have access to a comprehensive view of a patient's condition and treatment at the point of care. It is scheduled to be deployed hospital-wide this summer.
"Accurate and timely patient data is at the heart of delivering quality care and through our collaboration with OpenText we will ensure that it will be available to all front line care staff where and when it is required," said Will Smart, the director of information management & technology at the Royal Free.
As Smart explains further, "For a complex hospital environment like ours, managing patient care using paper case-notes has been logistically very challenging. Tracking and moving paper case notes across a large physical estate has made it difficult to ensure that these are available where and when they are needed and has required a large administrative team. By digitising these case-notes we have the opportunity to improve the quality of the services we provide whilst reducing costs. We also believe that OpenText's Content Suite will provide the platform to enable us to digitise other paper-based corporate records and drive further efficiencies."
OpenText's Content Suite will help to secure and manage all patient information and records including images and unstructured data across the trust.
Benefits of OpenText Content Suite:
- Captures, processes, distributes, secures, manages and archives clinical and non-clinical content
- Streamlines patient record access, reduces processing errors and enables compliance throughout the lifecycle of the patient record
Through OpenText, the Royal Free will be able to:
- Enhance patient care: Helps doctors to make more informed decisions based on a complete picture of the patient
- Respond quickly and accurately: Never again will clinicians have to wait for paper files to be pulled
- Reduce operating costs and spend less time on compliance: eliminate paper records, including the cost of storing and maintaining them
Mark Bridger, the regional VP of UK, OpenText, said, "Keeping medical records accurate and immediately accessible will go a long way in improving patient care, help clinical staff do their jobs more efficiently and have the confidence to embrace digital opportunities as recommended in the NHS Digital Health Strategy. Because the Royal Free operates within such a complicated compliancy framework too, it means that delivering a set of Enterprise Content Management technologies that ticks all of the boxes is even more pivotal."
The Royal Free employs over 5,000 staff. The IT team numbers 180 and provides IM&T services to the trust as well as to Barnet and Chase Farm Hospitals NHS Trust. The Royal Free medical records library manages 700,000 patient case notes.
Learn more about OpenText EIM:
- Read the blog of Mark Barrenechea,OpenText's CEO
- Read the Healthcare Industry focus at http://www.ot.co.uk/What-We-Do/Industries/Healthcare
- Connect with OpenText:
About OpenText OpenText provides Enterprise Information Management software that helps companies of all sizes and industries to manage, secure and leverage their unstructured business information, either in their data center or in the cloud. Over 50,000 companies already use OpenText solutions to unleash the power of their information. To learn more about OpenText (NASDAQ: OTEX; TSX: OTC), please visit: www.opentext.com.
Learn more about OpenText's Content Suite here: www.ot.co.uk/What-We-Do/Enterprise-Information-Management www.ot.co.uk/What-We-Do/Products/Enterprise-Content-Management/Content-Management/OpenText-Content-Suite-Platform
Certain statements in this press release may contain words considered forward-looking statements or information under applicable securities laws. These statements are based on OpenText's current expectations, estimates, forecasts and projections about the operating environment, economies and markets in which the company operates. These statements are subject to important assumptions, risks and uncertainties that are difficult to predict, and the actual outcome may be materially different. OpenText's assumptions, although considered reasonable by the company at the date of this press release, may prove to be inaccurate and consequently its actual results could differ materially from the expectations set out herein. For additional information with respect to risks and other factors which could occur, see OpenText's Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other securities filings with the SEC and other securities regulators. Unless otherwise required by applicable securities laws, OpenText disclaims any intention or obligations to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Copyright ©2014 Open Text Corporation. OpenText is a trademark or registered trademark of Open Text SA and/or Open Text ULC. The list of trademarks is not exhaustive of other trademarks, registered trademarks, product names, company names, brands and service names mentioned herein are property of Open Text SA or other respective owners. All rights reserved. For more information, visit: http://www.opentext.com/2/global/site-copyright.html_SKU.
About Royal Free London NHS Foundation Trust The Royal Free attracts patients from across the country and beyond to its specialist services in liver, kidney and bone marrow transplantation, haemophilia, surgery for hepatopancreatobiliary (HPB) conditions, clinical neurosciences, renal, HIV, infectious diseases, plastic surgery, immunology, vascular surgery, cardiology, amyloidosis and scleroderma and is a member of the academic health science partnership UCLPartners. For further information, visit www.royalfree.nhs.uk
SOURCE Open Text Corporation